Zepp Health Corporation ZEPP NYSE

Zepp Health Corporation (ZEPP) has shown exceptional revenue growth over the past 3 years, expanding from $4.1B to $1.8B (average +253.9%/yr). The company reported a net loss of $281M in its most recent fiscal year, with earnings trending at -58.6%/yr. The net profit margin is -15.5%, which is negative. The company has not reported a profit in any of the last 4 years tracked. The gross margin is 39.2% (moderate), with a +19.8pp trend over the period. With a market cap data available and MOAT composite score of 48/100, the company has a moderate competitive position.

Criteria proven by this page:

• GROWTH (58/100, Partial) — growth is present but not consistently above 5% across both metrics
• PAST (0/100, Fail) — the company has frequently reported losses. Looking at the full 11-year history, the company was profitable in 6 of 11 years — a mixed long-term record
• INCOME (10/100, Fail) — the company is currently operating at a loss
• MOAT (48/100, Partial) — some competitive advantages are present but not dominant

Overall SharesGrow Score: 26/100 with 0/7 criteria passed.